Clinical applications of BMPs - PubMed (original) (raw)
Review
Clinical applications of BMPs
Pietro De Biase et al. Injury. 2005 Nov.
Abstract
Bone morphogenetic proteins (BMPs) are polypeptides discovered by Marshall Urist in 1965 and later defined by his co-workers as multifunctional cytokines involved in osteoinduction. They are members of the transforming growth factor-beta superfamily with the exception of the BMP-1. Till now at least 20 BMPs have been identified and studied, but only BMP 2, 4 and 7 have been able in vitro to stimulate the entire process of stem cell differentiation into osteoblastic mature cells. After in vitro studies BMPs have been tested in preclinical and clinical studies, showing their definite potential in osteoinduction and have been approved for clinical use in open fracture of long bones, non-unions and vertebral arthrodesis. But more clinical use of these molecules is under investigation and the possibility of using gene therapy in selected pathologies seems the most appealing.
Similar articles
- Bone morphogenetic proteins in clinical applications.
Gautschi OP, Frey SP, Zellweger R. Gautschi OP, et al. ANZ J Surg. 2007 Aug;77(8):626-31. doi: 10.1111/j.1445-2197.2007.04175.x. ANZ J Surg. 2007. PMID: 17635273 Review. - Clinical applications of BMP-7: the UK perspective.
Giannoudis PV, Tzioupis C. Giannoudis PV, et al. Injury. 2005 Nov;36 Suppl 3:S47-50. doi: 10.1016/j.injury.2005.07.035. Injury. 2005. PMID: 16188550 Review. - The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman JR, Wang JC. Miyazaki M, et al. J Spinal Disord Tech. 2008 Jul;21(5):372-9. doi: 10.1097/BSD.0b013e31814cf51d. J Spinal Disord Tech. 2008. PMID: 18600149 - Is there a role for bone morphogenetic proteins in osteoporotic fractures?
Kanakaris NK, Petsatodis G, Tagil M, Giannoudis PV. Kanakaris NK, et al. Injury. 2009 Dec;40 Suppl 3:S21-6. doi: 10.1016/S0020-1383(09)70007-5. Injury. 2009. PMID: 20082786 - Bone morphogenetic proteins in open fractures: past, present, and future.
Nauth A, Ristiniemi J, McKee MD, Schemitsch EH. Nauth A, et al. Injury. 2009 Dec;40 Suppl 3:S27-31. doi: 10.1016/S0020-1383(09)70008-7. Injury. 2009. PMID: 20082787 Review.
Cited by
- Growth Factor Dose Tuning for Bone Progenitor Cell Proliferation and Differentiation on Resorbable Poly(propylene fumarate) Scaffolds.
Mishra R, Sefcik RS, Bishop TJ, Montelone SM, Crouser N, Welter JF, Caplan AI, Dean D. Mishra R, et al. Tissue Eng Part C Methods. 2016 Sep;22(9):904-13. doi: 10.1089/ten.TEC.2016.0094. Tissue Eng Part C Methods. 2016. PMID: 27558310 Free PMC article. - Tissue engineered strategies for pseudoarthrosis.
Longo UG, Trovato U, Loppini M, Rizzello G, Khan WS, Maffulli N, Denaro V. Longo UG, et al. Open Orthop J. 2012;6:564-70. doi: 10.2174/1874325001206010564. Epub 2012 Nov 30. Open Orthop J. 2012. PMID: 23248729 Free PMC article. - Osteogenic Differentiation Capacity of In Vitro Cultured Human Skeletal Muscle for Expedited Bone Tissue Engineering.
Miao C, Zhou L, Tian L, Zhang Y, Zhang W, Yang F, Liu T, Tang S, Liu F. Miao C, et al. Biomed Res Int. 2017;2017:8619385. doi: 10.1155/2017/8619385. Epub 2017 Jan 22. Biomed Res Int. 2017. PMID: 28210626 Free PMC article. - A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro.
Lee Y, Bae KJ, Chon HJ, Kim SH, Kim SA, Kim J. Lee Y, et al. Mol Cells. 2016 May 31;39(5):389-94. doi: 10.14348/molcells.2016.2300. Epub 2016 Mar 30. Mol Cells. 2016. PMID: 27025387 Free PMC article. - The potential impact of bone tissue engineering in the clinic.
Mishra R, Bishop T, Valerio IL, Fisher JP, Dean D. Mishra R, et al. Regen Med. 2016 Sep;11(6):571-87. doi: 10.2217/rme-2016-0042. Epub 2016 Aug 23. Regen Med. 2016. PMID: 27549369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous